Delgado José Antonio, Guillén-Grima Francisco, Moreno Cristina, Panizo Carlos, Pérez-Robles Carmen, Mata Juan José, Moreno Laura, Arana Paula, Chocarro Silvia, Merino Juana
Department of Immunology, Clínica Universidad de Navarra, University of Navarra, Spain.
Department of Preventive Medicine, Clínica Universidad de Navarra, University of Navarra, Spain.
J Immunol Methods. 2017 Mar;442:54-58. doi: 10.1016/j.jim.2016.12.006. Epub 2016 Dec 29.
Bone marrow (BM) aspirates used for flow-cytometry (FCM) studies are usually obtained from a second aspiration, as the primary aspirate is used for morphological assessment. For this reason, the FCM samples unavoidably contain some blood; although, good-quality samples contain only a small amount. It is of utmost importance to assess the quality of samples prior to FCM analysis; yet, contamination with peripheral blood (PB) is not evaluated in most laboratories, possibly because the methods available are either qualitative or too complex for daily practice. Here, we propose a simple FCM method to quantitatively evaluate PB contamination in BM aspirates, by analyzing the percentage of plasma cells and CD34 cells - two cell populations nearly absent from PB - and CD10 granulocytes, which comprise the majority of the PB granulocyte population. We analyzed these three populations in 122 BM aspirates from subjects without hematological disease, and identified samples with PB contamination by performing a hierarchical cluster analysis. A discriminant analysis yielded a function, which we named the PB contamination index (PBCI). This index value gives a quantitative indication about the degree of hemodilution of a given sample. A threshold was identified that discriminates low-quality samples. The method and the threshold proved to be useful in BM aspirates infiltrated with malignant cells, with the exception of cases where hematological disease altered two of the three parameters included in the index. We have easily implemented the PBCI calculation in our daily routine, and find it very helpful for an accurate interpretation of FCM results in a large proportion of BM specimens. Limitations of the technique are discussed.
用于流式细胞术(FCM)研究的骨髓穿刺液通常取自第二次穿刺,因为初次穿刺液用于形态学评估。因此,FCM样本不可避免地会含有一些血液;不过,高质量的样本仅含有少量血液。在进行FCM分析之前评估样本质量至关重要;然而,大多数实验室并未评估外周血(PB)污染情况,可能是因为现有的方法要么是定性的,要么对于日常实践来说过于复杂。在此,我们提出一种简单的FCM方法,通过分析浆细胞和CD34细胞(PB中几乎不存在的两种细胞群体)以及CD10粒细胞(构成PB粒细胞群体的大部分)的百分比,来定量评估骨髓穿刺液中的PB污染情况。我们分析了122例无血液系统疾病受试者的骨髓穿刺液中的这三种细胞群体,并通过进行层次聚类分析来识别存在PB污染的样本。判别分析得出了一个函数,我们将其命名为PB污染指数(PBCI)。该指数值可定量指示给定样本的血液稀释程度。确定了一个区分低质量样本的阈值。除了血液系统疾病改变了指数中包含的三个参数中的两个参数的情况外,该方法和阈值在恶性细胞浸润的骨髓穿刺液中被证明是有用的。我们已经在日常工作中轻松实现了PBCI计算,并发现它对于准确解读大部分骨髓标本的FCM结果非常有帮助。本文还讨论了该技术的局限性。